Camurus
OM:CAMX Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 31 Fair Values set on narratives written by author
WA
Consensus Narrative from 6 Analysts
Buvidal And Brixadi Expansion To Fuel Revenue Growth And Boost Profit Margins
Key Takeaways Strong R&D pipeline and successful regulatory progress signal future revenue growth from new treatments entering various markets. Robust sales and market expansion, particularly with Buvidal and Brixadi, highlight potential revenue upside and market penetration in significant regions.
View narrativeSEK 745.00
FV
13.8% undervalued intrinsic discount46.03%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
24 days ago author updated this narrative